SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-09-055657
Filing Date
2009-10-30
Accepted
2009-10-30 16:23:49
Documents
4
Period of Report
2009-10-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c91699e8vk.htm 8-K 9649
2 EXHIBIT 99.1 c91699exv99w1.htm EX-99.1 9202
3 GRAPHIC c91699p9169901.jpg GRAPHIC 10123
4 GRAPHIC c91699p9169902.jpg GRAPHIC 4436
  Complete submission text file 0000950123-09-055657.txt   40931
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 091148461
SIC: 2834 Pharmaceutical Preparations